AI
NVAX icon

Atom Investors’s Novavax NVAX Stock Holding History

Atom Investors’s Portfolio NVAX Stock Details NVAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$98.9K Sell
12,151
-96,017
-89% -$870K 0.01% 624
2025
Q4 		$727K Buy
+108,168
New +$815K 0.06% 347
2025
Q3 		– Sell
-20,439
Closed -$129K – 757
2025
Q2 		$129K Buy
+20,439
New +$135K 0.01% 536
2024
Q3 		– Sell
-12,323
Closed -$156K – 566
2024
Q2 		$156K Sell
12,323
-7,237
-37% -$72.8K 0.02% 435
2024
Q1 		$93.5K Buy
+19,560
New +$90.7K 0.01% 527

Other funds holding NVAX

SCM
Shah Capital Management Raleigh, North Carolina $521M AUM 46.95% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
S
Sanofi Paris, France $336M AUM 126.85% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Atom Investors's NVAX Position: Q1 2026 in Review

Atom Investors reduced its Novavax (NVAX) stake by 89% in Q1 2026, selling an estimated $870K and leaving 12,151 shares worth $98.9K. The position accounts for 0.01% of the portfolio, ranked #624.

Atom Investors first reported a position in NVAX in Q1 2024 and has held it in 5 quarters since. The position peaked at $727K in Q4 2025. 257 funds tracked by Wall St. Rank hold NVAX as of Q1 2026.

  • Atom Investors held 12,151 shares of Novavax worth $98.9K as of Q1 2026.
  • Atom Investors sold 96,017 Novavax shares in Q1 2026, an estimated $870K.
  • Novavax made up 0.01% of Atom Investors's portfolio in Q1 2026, its #624 holding.
  • Atom Investors first reported a position in Novavax in Q1 2024 and has held it in 5 quarters since.
  • Atom Investors's Novavax position peaked at $727K in Q4 2025.
  • 257 funds tracked by Wall St. Rank held Novavax as of Q1 2026.

Based on Atom Investors's 13F filing for Q1 2026, filed 15 May 2026.